Tubulocystic renal cell carcinoma: Is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases

10.1007/s00428-012-1367-z

Saved in:
Bibliographic Details
Main Authors: Steiner, P., Hora, M., Stehlik, J., Martinek, P., Vanecek, T., Petersson, F., Michal, M., Korabecna, M., Travnicek, I., Hes, O.
Other Authors: PATHOLOGY
Format: Article
Published: 2016
Subjects:
Online Access:http://scholarbank.nus.edu.sg/handle/10635/125641
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-125641
record_format dspace
spelling sg-nus-scholar.10635-1256412024-11-09T02:39:52Z Tubulocystic renal cell carcinoma: Is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases Steiner, P. Hora, M. Stehlik, J. Martinek, P. Vanecek, T. Petersson, F. Michal, M. Korabecna, M. Travnicek, I. Hes, O. PATHOLOGY Angiogenic pathways Antiangiogenic targeted therapy Kidney mRNA expression Protein expression Tubulocystic renal cell carcinoma 10.1007/s00428-012-1367-z Virchows Archiv 462 2 183-192 VARCE 2016-07-08T09:29:37Z 2016-07-08T09:29:37Z 2013-02 Article Steiner, P., Hora, M., Stehlik, J., Martinek, P., Vanecek, T., Petersson, F., Michal, M., Korabecna, M., Travnicek, I., Hes, O. (2013-02). Tubulocystic renal cell carcinoma: Is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases. Virchows Archiv 462 (2) : 183-192. ScholarBank@NUS Repository. https://doi.org/10.1007/s00428-012-1367-z 09456317 http://scholarbank.nus.edu.sg/handle/10635/125641 000314724300007 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Angiogenic pathways
Antiangiogenic targeted therapy
Kidney
mRNA expression
Protein expression
Tubulocystic renal cell carcinoma
spellingShingle Angiogenic pathways
Antiangiogenic targeted therapy
Kidney
mRNA expression
Protein expression
Tubulocystic renal cell carcinoma
Steiner, P.
Hora, M.
Stehlik, J.
Martinek, P.
Vanecek, T.
Petersson, F.
Michal, M.
Korabecna, M.
Travnicek, I.
Hes, O.
Tubulocystic renal cell carcinoma: Is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases
description 10.1007/s00428-012-1367-z
author2 PATHOLOGY
author_facet PATHOLOGY
Steiner, P.
Hora, M.
Stehlik, J.
Martinek, P.
Vanecek, T.
Petersson, F.
Michal, M.
Korabecna, M.
Travnicek, I.
Hes, O.
format Article
author Steiner, P.
Hora, M.
Stehlik, J.
Martinek, P.
Vanecek, T.
Petersson, F.
Michal, M.
Korabecna, M.
Travnicek, I.
Hes, O.
author_sort Steiner, P.
title Tubulocystic renal cell carcinoma: Is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases
title_short Tubulocystic renal cell carcinoma: Is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases
title_full Tubulocystic renal cell carcinoma: Is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases
title_fullStr Tubulocystic renal cell carcinoma: Is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases
title_full_unstemmed Tubulocystic renal cell carcinoma: Is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases
title_sort tubulocystic renal cell carcinoma: is there a rational reason for targeted therapy using angiogenic inhibition? analysis of seven cases
publishDate 2016
url http://scholarbank.nus.edu.sg/handle/10635/125641
_version_ 1821202437672796160